Zobrazeno 1 - 10
of 39
pro vyhledávání: '"NJ Goulden"'
Autor:
D Baines, NJ Goulden, Colin G. Steward, F Katz, A Oakhill, M N Potter, P G Martin, J M Chessells, Kenneth Langlands
Publikováno v:
Blood. 83:1355-1362
Ig heavy-chain (IgH) and partial V delta 2-D delta 3 T-cell receptor (TCR) gene rearrangements were investigated, by polymerase chain reaction (PCR) amplification and sequence analysis, in 52 patients at presentation and first relapse and in 14 at bo
Autor:
NJ Goulden, Colin G. Steward
Publikováno v:
Best practiceresearch. Clinical haematology. 15(1)
The toxicity and expense of allogeneic stem cell transplantation (ASCT) is such that it is currently reserved for the treatment of children deemed to be at unacceptable risk of relapse when treated with chemotherapy alone. Although ASCT carries at le
Publikováno v:
Europe PubMed Central
Publikováno v:
Blood. 84:1352-1353
Autor:
NJ Goulden, J Cornish, Derwood Pamphilon, Colin G. Steward, Kenneth Langlands, A Oakhill, M N Potter
Publikováno v:
Blood. 84:1352-1353
Autor:
Colin Steward, Nj, Goulden, Katz F, Baines D, Pg, Martin, Langlands K, Mn, Potter, Jm, Chessells, Oakhill A
Publikováno v:
Europe PubMed Central
Ig heavy-chain (IgH) and partial V delta 2-D delta 3 T-cell receptor (TCR) gene rearrangements were investigated, by polymerase chain reaction (PCR) amplification and sequence analysis, in 52 patients at presentation and first relapse and in 14 at bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0335908520dbb32bfe57902fc0eeee2f
http://europepmc.org/abstract/med/8118037
http://europepmc.org/abstract/med/8118037
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::530c56d072c9b56bbd1666147ca4e721
http://europepmc.org/abstract/med/8049454
http://europepmc.org/abstract/med/8049454
Autor:
Cj, Knechtli, Nj, Goulden, Jp, Hancock, Vl, Grandage, El, Harris, Rj, Garland, Cg, Jones, Aw, Rowbottom, Lp, Hunt, Af, Green, Clarke E, Aw, Lankester, Jm, Cornish, Dh, Pamphilon, Colin Steward, Oakhill A
Publikováno v:
Europe PubMed Central
The efficacy of allografting in acute lymphoblastic leukemia (ALL) is heavily influenced by remission status at the time of transplant. Using polymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis, we have investigated retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c157dd15d192bacf3244d4af5e9aa0cd
http://europepmc.org/abstract/med/9834212
http://europepmc.org/abstract/med/9834212
Autor:
Sidhu J; Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India.; Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India., Masurekar AN; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Gogoi MP; Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India., Fong C; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Ioannou T; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Lodhi T; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Parker C; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Liu J; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Kirkwood AA; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College, London, UK., Moorman AV; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Das K; Interdisciplinary Statistical Research Unit, Indian Statistical Institute, Kolkata, India., Goulden NJ; Department of Haematology, Great Ormond Street Hospital for Children, London, UK., Vora A; Department of Haematology, Great Ormond Street Hospital for Children, London, UK., Saha V; Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India.; Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India.; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Krishnan S; Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India.; Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India.; Childrens Cancer Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Jul; Vol. 198 (1), pp. 142-150. Date of Electronic Publication: 2022 Mar 29.
Autor:
Jackson RK; Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK., Liebich M; Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Münster, Germany., Berry P; Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK., Errington J; Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK., Liu J; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK., Parker C; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK., Moppett J; Department of Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, UK., Samarasinghe S; Department of Haematology, Great Ormond Street Hospital for Children, London, UK., Hough R; University College Hospital, London, UK., Rowntree C; University Hospital of Wales, Cardiff, UK., Goulden NJ; Department of Haematology, Great Ormond Street Hospital for Children, London, UK., Vora A; Department of Paediatric Haematology, Great Ormond Street Hospital, UK., Kearns PR; Cancer Research UK Clinical Trials Unit, National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Cancer and Genomic Studies, University of Birmingham, UK., Saha V; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK; Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India., Hempel G; Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Münster, Germany., Irving JAE; Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK., Veal GJ; Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK. Electronic address: G.J.Veal@ncl.ac.uk.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Oct; Vol. 120, pp. 75-85. Date of Electronic Publication: 2019 Sep 06.